MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

Начало・Списък с акции・Novocure Ltd

Novocure Ltd

Затворен

СекторЗдравеопазване

13.07 1.4

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

12.89

Максимум

13.47

Ключови измерители
By Trading Economics
Приходи	2.9M -37M
Продажби	8.4M 167M
EPS	-0.33
Марж на печалбата	-22.29
Служители	1,488
EBITDA	9.7M -26M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+87.94% upside

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-32M 1.5B
Предишно отваряне	11.67
Предишно затваряне	13.07

Настроения в новините

By Acuity

100%

349 / 374 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Bearish Evidence

16.31 / 18.14 Подкрепа & съпротива

Novocure Ltd Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

2.01.2026 г., 22:45 ч. UTC

Значими двигатели на пазара

GH Research Shares Up, Plans to Provide Update on New Drug Application

2.01.2026 г., 22:13 ч. UTC

Пазарно говорене

Печалби

Tesla Seen As Quiet on Artificial-Intelligence Efforts -- Market Talk

2.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Tech, Media & Telecom Roundup: Market Talk

2.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

2.01.2026 г., 21:07 ч. UTC

Печалби

Tesla Stock Pops and Drops After Fourth-Quarter Deliveries. -- Barrons.com

2.01.2026 г., 20:09 ч. UTC

Пазарно говорене

Oil Futures Slip in First Trading Day of the Year -- Market Talk

2.01.2026 г., 19:48 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Kick Off 2026 With A Loss -- Market Talk

2.01.2026 г., 18:53 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

2.01.2026 г., 18:53 ч. UTC

Пазарно говорене

Mexico PMIs Show Manufacturing Weakness in December -- Market Talk

2.01.2026 г., 17:56 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Meta's Manus Acquisition May Help Fill AI Monetization Gap -- Market Talk

2.01.2026 г., 17:50 ч. UTC

Пазарно говорене

Apparel Industry Seen With Strength Across Income Levels -- Market Talk

2.01.2026 г., 17:20 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

2.01.2026 г., 16:33 ч. UTC

Пазарно говорене

Remittances to Mexico Fell 5.7% in November -- Market Talk

2.01.2026 г., 16:18 ч. UTC

Пазарно говорене

Tesla Dethroned as World's Largest EV Maker -- Market Talk

2.01.2026 г., 15:48 ч. UTC

Печалби

Software Has Been Battered by AI. Shopify, Veeva, and 3 More Stocks to Play a Turnaround. -- Barrons.com

2.01.2026 г., 15:17 ч. UTC

Пазарно говорене

Tesla Expected to Make Its Switch to Robotics, AI in 2026 -- Market Talk

2.01.2026 г., 15:01 ч. UTC

Пазарно говорене

Sable Seen Nearing Production Relaunch After Court Ruling -- Market Talk

2.01.2026 г., 15:00 ч. UTC

Печалби

The Maker of Biscoff Cookies Bets on a Global Expansion -- WSJ

2.01.2026 г., 14:56 ч. UTC

Пазарно говорене

Tesla's Sales Drop Was Better Than Feared -- Market Talk

2.01.2026 г., 14:20 ч. UTC

Пазарно говорене

Capstone Copper's Mantoverde Strike Could Be Costly -- Market Talk

2.01.2026 г., 14:20 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

2.01.2026 г., 14:13 ч. UTC

Пазарно говорене

Oil Futures Open Year Lower on Oversupply Concerns -- Market Talk

2.01.2026 г., 13:39 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Open Year Lower -- Market Talk

2.01.2026 г., 13:01 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Unicredit Could Buy Delfin's BMPS Stake, Launch Full Takeover, Equita Says -- Market Talk

2.01.2026 г., 12:45 ч. UTC

Пазарно говорене

Emerging-Market Dollar Bonds Record Strong Returns in 2025 -- Market Talk

2.01.2026 г., 11:48 ч. UTC

Пазарно говорене

European Gas Climbs as Cold Weather Bites -- Market Talk

2.01.2026 г., 11:36 ч. UTC

Пазарно говорене

Treasury Yields, Dollar Edge Higher as Near-Term Fed Rate Cut Looks Unlikely -- Market Talk

2.01.2026 г., 11:30 ч. UTC

Пазарно говорене

Copper Rally Continues, Spurred by Supply Shocks -- Market Talk

2.01.2026 г., 11:29 ч. UTC

Пазарно говорене

Dollar Rises After Posting Worst Year Since 2017 -- Market Talk

2.01.2026 г., 11:15 ч. UTC

Пазарно говорене

Global Energy Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

Novocure Ltd Прогноза

Ценова цел

By TipRanks

87.94% нагоре

12-месечна прогноза

Среден 24.3 USD 87.94%

Висок 42 USD

Нисък 13.5 USD

Според 5 анализатори от Wall Street, предложили 12-месечна ценова цел за Novocure Ltd през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

5 ratings

Купи

Задържане

Продай

Според 5 анализатори, дали борсови рейтинги на Novocure Ltd през последните 3 месеца.

Техническа оценка

By Trading Central

16.31 / 18.14Подкрепа & съпротива

Recent bearish events outweigh bullish events.

All events are bearish.

Bearish events outweigh bullish events.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Novocure Ltd

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.